Iclepertin

N/A

Report date: 2026/05/06 20:02:28
NME

Base Information

Drug NameIclepertin
Drug Alias NameBI-425809
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycine transporter 1 inhibitors
TargetsGlycine transporter 1
Therapy Area/IndicationsSchizophreniaRenal InsufficiencyAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[42] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. KgBoehringer Ingelheim Pharma Gmbh & Co KgBoehringer Ingelheim International Gmbh +[4] 
Inactive CompaniesN/A
Active IndicationsSchizophreniaRenal InsufficiencyHepatic Insufficiency
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A